774 related articles for article (PubMed ID: 12169073)
21. Sexual function in postpartum women treated for depression: results from a randomized trial of nortriptyline versus sertraline.
Lanza di Scalea T; Hanusa BH; Wisner KL
J Clin Psychiatry; 2009 Mar; 70(3):423-8. PubMed ID: 19284932
[TBL] [Abstract][Full Text] [Related]
22. Switching patients from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine in the maintenance of response for depression.
Miner CM; Brown EB; Gonzales JS; Munir R
J Clin Psychiatry; 2002 Mar; 63(3):232-40. PubMed ID: 11926723
[TBL] [Abstract][Full Text] [Related]
23. A double-blind multicenter trial comparing sertraline and fluoxetine in outpatients with major depression.
Bennie EH; Mullin JM; Martindale JJ
J Clin Psychiatry; 1995 Jun; 56(6):229-37. PubMed ID: 7775364
[TBL] [Abstract][Full Text] [Related]
24. A double-blind comparison of sertraline and fluoxetine in the treatment of major depressive episode in outpatients.
Sechter D; Troy S; Paternetti S; Boyer P
Eur Psychiatry; 1999 Mar; 14(1):41-8. PubMed ID: 10572324
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of sertraline in a 12-week trial for generalized anxiety disorder.
Allgulander C; Dahl AA; Austin C; Morris PL; Sogaard JA; Fayyad R; Kutcher SP; Clary CM
Am J Psychiatry; 2004 Sep; 161(9):1642-9. PubMed ID: 15337655
[TBL] [Abstract][Full Text] [Related]
26. [Milnacipran and venlafaxine at flexible doses (up to 200 mg/d) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomised, double blind exploratory study].
Olié JP; Gourion D; Montagne A; Rostin M; Poirier MF
Encephale; 2009 Dec; 35(6):595-604. PubMed ID: 20004291
[TBL] [Abstract][Full Text] [Related]
27. Topiramate augmentation in patients with resistant major depressive disorder: a double-blind placebo-controlled clinical trial.
Mowla A; Kardeh E
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):970-3. PubMed ID: 21291943
[TBL] [Abstract][Full Text] [Related]
28. Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies.
Clayton AH; Croft HA; Horrigan JP; Wightman DS; Krishen A; Richard NE; Modell JG
J Clin Psychiatry; 2006 May; 67(5):736-46. PubMed ID: 16841623
[TBL] [Abstract][Full Text] [Related]
29. A randomized, double-blind, placebo-controlled, 8-week study of vilazodone, a serotonergic agent for the treatment of major depressive disorder.
Khan A; Cutler AJ; Kajdasz DK; Gallipoli S; Athanasiou M; Robinson DS; Whalen H; Reed CR
J Clin Psychiatry; 2011 Apr; 72(4):441-7. PubMed ID: 21527122
[TBL] [Abstract][Full Text] [Related]
30. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
Lin CH; Lin SH; Jang FL
J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
[TBL] [Abstract][Full Text] [Related]
31. Evidence for efficacy and tolerability of vilazodone in the treatment of major depressive disorder: a randomized, double-blind, placebo-controlled trial.
Rickels K; Athanasiou M; Robinson DS; Gibertini M; Whalen H; Reed CR
J Clin Psychiatry; 2009 Mar; 70(3):326-33. PubMed ID: 19284933
[TBL] [Abstract][Full Text] [Related]
32. Superior antidepressant efficacy results of agomelatine versus fluoxetine in severe MDD patients: a randomized, double-blind study.
Hale A; Corral RM; Mencacci C; Ruiz JS; Severo CA; Gentil V
Int Clin Psychopharmacol; 2010 Nov; 25(6):305-14. PubMed ID: 20856123
[TBL] [Abstract][Full Text] [Related]
33. Safety and efficacy of sertraline for depression in patients with CHF (SADHART-CHF): a randomized, double-blind, placebo-controlled trial of sertraline for major depression with congestive heart failure.
Jiang W; O'Connor C; Silva SG; Kuchibhatla M; Cuffe MS; Callwood DD; Zakhary B; Henke E; Arias RM; Krishnan R;
Am Heart J; 2008 Sep; 156(3):437-44. PubMed ID: 18760123
[TBL] [Abstract][Full Text] [Related]
34. Antidepressants effects of Rhodiola capsule combined with sertraline for major depressive disorder: A randomized double-blind placebo-controlled clinical trial.
Gao L; Wu C; Liao Y; Wang J
J Affect Disord; 2020 Mar; 265():99-103. PubMed ID: 32090788
[TBL] [Abstract][Full Text] [Related]
35. The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomised trial.
Lewis G; Duffy L; Ades A; Amos R; Araya R; Brabyn S; Button KS; Churchill R; Derrick C; Dowrick C; Gilbody S; Fawsitt C; Hollingworth W; Jones V; Kendrick T; Kessler D; Kounali D; Khan N; Lanham P; Pervin J; Peters TJ; Riozzie D; Salaminios G; Thomas L; Welton NJ; Wiles N; Woodhouse R; Lewis G
Lancet Psychiatry; 2019 Nov; 6(11):903-914. PubMed ID: 31543474
[TBL] [Abstract][Full Text] [Related]
36. Sertraline versus fluoxetine in the treatment of major depression: a combined analysis of five double-blind comparator studies.
Feiger AD; Flament MF; Boyer P; Gillespie JA
Int Clin Psychopharmacol; 2003 Jul; 18(4):203-10. PubMed ID: 12817154
[TBL] [Abstract][Full Text] [Related]
37. Double-blind, multicenter comparative study of sertraline and amitriptyline in hospitalized patients with major depression.
Möller HJ; Gallinat J; Hegerl U; Arató M; Janka Z; Pflug B; Bauer H
Pharmacopsychiatry; 1998 Sep; 31(5):170-7. PubMed ID: 9832348
[TBL] [Abstract][Full Text] [Related]
38. Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study.
Van Ameringen MA; Lane RM; Walker JR; Bowen RC; Chokka PR; Goldner EM; Johnston DG; Lavallee YJ; Nandy S; Pecknold JC; Hadrava V; Swinson RP
Am J Psychiatry; 2001 Feb; 158(2):275-81. PubMed ID: 11156811
[TBL] [Abstract][Full Text] [Related]
39. Sertraline treatment for generalized anxiety disorder: a randomized, double-blind, placebo-controlled study.
Brawman-Mintzer O; Knapp RG; Rynn M; Carter RE; Rickels K
J Clin Psychiatry; 2006 Jun; 67(6):874-81. PubMed ID: 16848646
[TBL] [Abstract][Full Text] [Related]
40. Sertraline: a review of its use in the management of major depressive disorder in elderly patients.
Muijsers RB; Plosker GL; Noble S
Drugs Aging; 2002; 19(5):377-92. PubMed ID: 12093324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]